H. Abodakpi

Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

V. Tam, R. Cantón, Song Gao, 2018, Antimicrobial Agents and Chemotherapy.

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways

V. Tam, C. Arias, J. Munita, 2018, Case reports in infectious diseases.

Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital

Katrina Chan, V. Tam, R. Cantón, 2017, Journal of chemotherapy.

New β-Lactam–β-Lactamase Inhibitor Combinations

L. Leibovici, V. Tam, D. Yahav, 2020, Clinical Microbiology Reviews.

What the Clinical Microbiologist Should Know About PK/PD in the Era of Emerging Multidrug-Resistance: Beta-Lactam/Beta-Lactamase Inhibitor Combinations

A. Wanger, H. Abodakpi, 2019 .

What the Clinical Microbiologist Should Know About Pharmacokinetics/Pharmacodynamics in the Era of Emerging Multidrug Resistance: Focusing on β-Lactam/β-Lactamase Inhibitor Combinations.

V. Tam, A. Wanger, H. Abodakpi, 2019, Clinics in laboratory medicine.

Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model

V. Tam, Song Gao, Jian Zhou, 2017, Antimicrobial Agents and Chemotherapy.

Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity

V. Tam, C. Arias, J. Munita, 2017, Open Forum Infectious Diseases.

Analytical and Functional Determination of Polymyxin B Protein Binding in Serum

V. Tam, D. Chow, H. Abodakpi, 2015, Antimicrobial Agents and Chemotherapy.

A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae.

V. Tam, H. Abodakpi, J. Zhou, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria.

Paul R. Merlau, M. Nikolaou, Katrina Chan, 2020, The Journal of antimicrobial chemotherapy.